Nucleic acid test

Results: 49



#Item
31cobas®D CT/NO Test and cobas®D CT/NO Test, version[removed]k) Summary Report Roche Molecular Systems, Inc. Pleasanton, CA[removed]

cobas®D CT/NO Test and cobas®D CT/NO Test, version[removed]k) Summary Report Roche Molecular Systems, Inc. Pleasanton, CA[removed]

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-06-06 11:54:39
32cobasID CT/NG Test Section 5: 510(k) Summary 510(k) Summary Report Roche Molecular Systems, Inc. Pleasanton, CA[removed]

cobasID CT/NG Test Section 5: 510(k) Summary 510(k) Summary Report Roche Molecular Systems, Inc. Pleasanton, CA[removed]

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-01-14 08:01:16
33Verigen

Verigen" CYP2CI9 Nucleic Acid Test (CYP2CI9 Test) Traditional 510(k) Pre-Market Notification 51 0(K) Summary 510(k) Number:

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-12-06 10:13:11
34Verigene

Verigene" C difficile Nucleic Acid Test (CDF) November 27, 2Q12 Traditional 510(k) Pre-Market Notification

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-01-09 11:27:41
35Organization  Genetic Disorders FDA-Approved CE Marked  Certified & Standardized Reference Materials

Organization Genetic Disorders FDA-Approved CE Marked Certified & Standardized Reference Materials

Add to Reading List

Source URL: wwwn.cdc.gov

Language: English - Date: 2013-06-20 10:04:04
36Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the

Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the

Add to Reading List

Source URL: www.fda.gov

Language: English
37HIV QT Nov. 13, 2001  NucliSens HIV-1 QT NASBA Diagnostics  For in vitro diagnostic use.

HIV QT Nov. 13, 2001 NucliSens HIV-1 QT NASBA Diagnostics For in vitro diagnostic use.

Add to Reading List

Source URL: www.fda.gov

Language: English
38BK060030 510(k) Summary:  ACCURUN 804 Nucleic Acid Negative Quality Control

BK060030 510(k) Summary: ACCURUN 804 Nucleic Acid Negative Quality Control

Add to Reading List

Source URL: www.fda.gov

Language: English
39HCV NATs for Organ-Donor Screening  Angela M. Caliendo, MD, PhD Professor and Vice Chair Pathology and Laboratory Medicine Emory University School of Medicine

HCV NATs for Organ-Donor Screening Angela M. Caliendo, MD, PhD Professor and Vice Chair Pathology and Laboratory Medicine Emory University School of Medicine

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2012-02-15 09:31:07
40Advantages and disadvantages of FDA approved HIV immunoassays used for screening by generation and platform

Advantages and disadvantages of FDA approved HIV immunoassays used for screening by generation and platform

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2014-06-23 17:12:24